• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION TACTRA MALLEABLE PENILE PROTHESIS; PROSTHESIS PENILE Back to Search Results
Model Number 720081-01
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Necrosis (1971)
Event Date 05/08/2021
Event Type  Injury  
Event Description
It was reported the patient underwent a surgical procedure to remove their tactra malleable penile prosthesis approximately two weeks post-implant due to necrosis of the glans.It was noted that the patient is (b)(6) years old and diabetic; they also contracted covid-19 following implant of the tactra.No additional patient complications were reported; the patient was stable following the procedure.
 
Manufacturer Narrative
Investigation summary: based on the information available, there was no device available for analysis and there was no report of a device performance allegation during treatment.The reported necrosis is a known risk associated with penile prosthesis procedures and is noted as such in the instructions for use (ifu).Dhr review: review of manufacturing documentation was performed to ensure that all required in-process and final inspections and testing were completed.Review of the manufacturing records found no evidence that the device failed to meet applicable product specifications prior to shipment from boston scientific.Device technical analysis: the device is not available for analysis; therefore, no physical or visual analysis of the product could be performed.Labeling review: the tactra instructions for use (ifu) was reviewed.The patient symptom of necrosis was found to be listed in the ifu.Medical review assessment determined the data reasonably suggest the clinical event is anticipated in nature and severity as per the ifu and hazard analysis (ha).Investigation conclusion: based on the information available, a conclusion code of known inherent risk of device was assigned to this investigation.
 
Event Description
It was reported the patient underwent a surgical procedure to remove their tactra malleable penile prosthesis approximately two weeks post-implant due to necrosis of the glans.It was noted that the patient is 62 years old and diabetic; they also contracted covid-19 following implant of the tactra.No additional patient complications were reported; the patient was stable following the procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
TACTRA MALLEABLE PENILE PROTHESIS
Type of Device
PROSTHESIS PENILE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
MDR Report Key11886179
MDR Text Key252691634
Report Number2124215-2021-14777
Device Sequence Number1
Product Code FAE
UDI-Device Identifier08714729979357
UDI-Public08714729979357
Combination Product (y/n)N
PMA/PMN Number
K183619
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Type of Report Initial,Followup
Report Date 06/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Model Number720081-01
Device Catalogue Number720081-01
Device Lot Number0025827005
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 05/08/2021
Initial Date FDA Received05/26/2021
Supplement Dates Manufacturer Received06/04/2021
Supplement Dates FDA Received06/15/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
-
-